Skip to content
jw van zyl inc

Regulated life sciences · South Africa

Life sciences deals, trials and market entry in South Africa.

Clinical trial agreements, licensing, M&A contract work and distribution for pharma, biotech and CROs. Every matter is led by Wilhelm van Zyl, after a decade in clinical research and pharmaceutical operations, including clinical-trial contracting and study budgets.

Wilhelm van Zyl, director of JW van Zyl Inc

Who you work with

Wilhelm van Zyl

Director and attorney of the High Court of South Africa. You deal with him directly, from the first call to signature. Full background · LinkedIn

A decade

In clinical research and pharmaceutical operations: clinical-trial contracting and study budgets for global sponsors, and regional business operations.

Across Africa

Study start-up agreements in multiple African jurisdictions, before founding the firm.

Published

On clinical supply and regulatory strategy in Clinical Supply Leader and Pharmaceutical Online.

How clients instruct the firm

Three ways to instruct the firm.

Global and regional life-sciences teams reach a point where a South African agreement, structure or regulatory responsibility has to be resolved locally. JW van Zyl Inc provides that local legal capacity.

A defined project
One scoped mandate with agreed deliverables and a fixed or bounded fee: a market entry, a distributor change, a set of agreements.
A transaction
The South African regulatory and legal workstream inside a deal: diligence, risk allocation, and the conditions the deal cannot leave behind.
Continuing outside counsel
Defined monthly capacity under a recurring mandate, for teams that need South African legal capability without another permanent hire.

When JW van Zyl Inc is engaged

Six situations that bring the firm in.

01

Entering South Africa

Establishing regulated operations from outside South Africa: entity, licensing, distribution structure, regulatory responsibility and the first commercial agreements.

02

Starting a South African clinical programme

Site activation, sponsor, CRO and site contracting, insurance and indemnity, POPIA, and the ethics and SAHPRA interface for a specific trial or programme.

03

Changing a distributor or regulatory holder

A structural change to who holds the regulatory position or the supply chain: contract, transition, liability allocation and product responsibility.

04

Acquiring a regulated healthcare business

Regulatory, contract and IP diligence on a South African healthcare or life-sciences target: surviving obligations, licence transferability and the compliance conditions the deal cannot leave behind.

05

Temporary in-house legal capacity

A continuing South African outside-counsel workstream under a defined recurring mandate, priced monthly, for teams that need local capability without another permanent hire.

Sectors
Pharmaceutical · Biotechnology · Clinical research: sponsors, CROs, sites · Medical devices & diagnostics · Funded health programmes · Healthcare investors & manufacturers
Regulatory & governance
SAHPRA · Section 21 authorisations · SANCTR registration · Research ethics committees · POPIA / PAIA · Company & director governance · A Legal Practice Council–regulated practice

How the firm is engaged

A defined scope, agreed in writing before work begins.

Set out the parties, the situation and the deadline. The firm checks conflicts and responds in writing from info@jwvanzylinc.com normally within two business days.